Emergent BioSolutions (EBS) Other Non Operating Income (2011 - 2026)

Emergent BioSolutions' Other Non Operating Income history runs 16 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 80.06% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at -$7.3 million (down 109.91% YoY), while the FY2025 annual figure was -$12.2 million, down 2133.33% from the prior year.
• Other Non Operating Income was $13.9 million for Q1 2026 at Emergent BioSolutions, up from -$13.8 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $69.7 million in Q1 2025 to a low of -$15.2 million in Q4 2024.
• Historically, Other Non Operating Income has averaged $3.2 million across 5 years, with a median of -$3.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income tumbled 458.33% in 2022, then soared 2150.0% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $6.7 million in 2022, then sank by 31.34% to $4.6 million in 2023, then tumbled by 430.43% to -$15.2 million in 2024, then climbed by 9.21% to -$13.8 million in 2025, then jumped by 200.72% to $13.9 million in 2026.
• The last three Other Non Operating Income figures came in at $13.9 million (Q1 2026), -$13.8 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.